158 related articles for article (PubMed ID: 37191760)
1. Effect of Copper and Zinc Ions on Biochemical and Molecular Characteristics of Calcium Oxalate Renal Stones: a Controlled Clinical Study.
Taha SAY; Shokeir AA; Mortada WI; Awadalla A; Barakat LAA
Biol Trace Elem Res; 2024 Feb; 202(2):410-422. PubMed ID: 37191760
[TBL] [Abstract][Full Text] [Related]
2. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
[TBL] [Abstract][Full Text] [Related]
3. Zn
Wu F; Cheng Y; Zhou J; Liu X; Lin R; Xiang S; Liu Z; Wang C
Int J Biol Macromol; 2023 Apr; 234():123320. PubMed ID: 36682657
[TBL] [Abstract][Full Text] [Related]
4. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
Ma MC; Chen YS; Huang HS
Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
[TBL] [Abstract][Full Text] [Related]
6. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
7. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
8. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
Sikora P; Zajaczkowska M; Hoppe B
Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
[TBL] [Abstract][Full Text] [Related]
9. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
10. Premature Senescence and Telomere Shortening Induced by Oxidative Stress From Oxalate, Calcium Oxalate Monohydrate, and Urine From Patients With Calcium Oxalate Nephrolithiasis.
Chuenwisad K; More-Krong P; Tubsaeng P; Chotechuang N; Srisa-Art M; Storer RJ; Boonla C
Front Immunol; 2021; 12():696486. PubMed ID: 34745087
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of phosphate in calcium oxalate renal stones.
Ohman S; Larsson L; Tiselius HG
Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():59-63. PubMed ID: 1536527
[TBL] [Abstract][Full Text] [Related]
12. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
[TBL] [Abstract][Full Text] [Related]
13. Evidence for disordered acid-base handling in calcium stone-forming patients.
Worcester EM; Bergsland KJ; Gillen DL; Coe FL
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
Huang HS; Ma MC; Chen CF; Chen J
Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
[TBL] [Abstract][Full Text] [Related]
16. Urine osmolality predicts calcium-oxalate crystallization risk in patients with recurrent urolithiasis.
Kavouras SA; Suh HG; Vallet M; Daudon M; Mauromoustakos A; Vecchio M; Tack I
Urolithiasis; 2021 Oct; 49(5):399-405. PubMed ID: 33635363
[TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
18. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
19. Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6.
Liu Y; Jin X; Ma Y; Jian Z; Wei Z; Xiang L; Sun Q; Qi S; Wang K; Li H
mSystems; 2021 Dec; 6(6):e0104521. PubMed ID: 34783577
[TBL] [Abstract][Full Text] [Related]
20. Role of the urinary calcium in the growth of calcium stone.
Murayama T; Sakai N; Takano T; Yamada T
Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
